Evotec AG (OTCMKTS:EVTCY) is scheduled to be releasing its earnings data before the market opens on Wednesday, November 8th. Analysts expect Evotec AG to post earnings of $0.12 per share for the quarter.

TRADEMARK VIOLATION NOTICE: “Evotec AG (EVTCY) Set to Announce Earnings on Wednesday” was first posted by American Banking News and is the property of of American Banking News. If you are viewing this news story on another publication, it was stolen and reposted in violation of United States and international trademark and copyright law. The original version of this news story can be viewed at https://www.americanbankingnews.com/2017/11/03/evotec-ag-evtcy-set-to-announce-earnings-on-wednesday.html.

Evotec AG Company Profile

Evotec AG is a drug discovery and development company. The Company operates through two segments. The EVT Execute segment provides standalone drug discover services on a typical fee-for-service basis or integrated drug discovery collaborations on partners’ target through a range of commercial structures, including research fees, milestones and/or royalties.

Receive News & Ratings for Evotec AG Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Evotec AG and related companies with MarketBeat.com's FREE daily email newsletter.